Overall, mammography prevalence declined from 69.9% to 59.2% among women aged 40 to 49 years and from 81.3% to 77.0% in women ...

The FDA proposes MRD negativity as an accelerated approval end point to speed access to novel myeloma therapies.

An article published by AOL referenced a study published in the November 2019 issue of The American Journal of Managed Care® ...

Building on insights from last year, experts across sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

Adults can take the CAR T-cell therapy for relapsed or refractory mantle cell lymphoma after the full approval of the ...

At the American Academy of Dermatology (AAD) 2026 Annual Meeting, experts emphasized the value of in-person networking, ...

The CDC announced on April 1 that they would be downsizing their operations, leading to the pause of diagnostic testing for mpox, rabies, and more than 2 dozen other infectious diseases. 1 The CDC has ...

The ongoing disruption in the Middle East is affecting a meaningful portion of global clinical research, with 6.7% of active ...

Conclusions: Our findings suggest that Medicare inpatient encounters are associated with higher coding intensity than ...

HB 4965 permits switching to an alternative medically appropriate treatment of equal or lesser value after initial approval, ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...